Annual Drug Patent Expirations for UTIBRON
Utibron is a drug marketed by Novartis and is included in one NDA. There are thirteen patents protecting this drug.
Drug patent litigation for UTIBRON.
This drug has three hundred and forty-two patent family members in forty-four countries.
The generic ingredient in UTIBRON is glycopyrrolate; indacaterol maleate. Additional details are available on the glycopyrrolate; indacaterol maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
